Using Antiretrovirals for Chronic Fatigue Syndrome Has Sparked Controversy
September 23, 2011
In an age where there are almost 8,800 HIV-positive Americans anxiously on the AIDS Drug Assistance Program waiting list, new reports are coming out that HIV medications are being used by, and experimented on, people with chronic fatigue syndrome.
Understandably, this development has created an uproar with all eyes focused on Gilead Sciences, the makers of Viread, the HIV drug being used to treat chronic fatigue syndrome. The New York Times reported:
When medications have proved safe and effective for most patients, it is standard practice for pharmaceutical companies to see if the drugs have other applications. But with H.I.V. drugs, the practice has been unusually contentious, fostering debates about questionable science, safety and profiteering, and concerns that thousands of Americans infected with H.I.V. cannot get the medications ...
Ged Kenslea, a spokesman for AIDS Healthcare Foundation, told the Times, "They are giving these lifesaving drugs to people who do not have H.I.V., while those who need them are going without."
Do you agree with Kenslea? And with the recent successes of PrEP, should AIDS meds be used for people who are not living with HIV/AIDS?
Kellee Terrell is the former news editor for TheBody.com and TheBodyPRO.com.
Copyright © 2011 The HealthCentral Network, Inc. All rights reserved.
This article was provided by TheBody.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)